ArticleBMC medicine2022

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.

Mei-Mei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.